Anterior gradient 2: A novel player in tumor cell biology

Cancer Letters

Volumn 304, Issue 1, 2011, Pages 1-7

  Brychtova, Veronika ^a   Vojtesek, Borivoj ^a   Hrstka, Roman ^a  

^a MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

AGR2; Barrett esophagus; Breast cancer; Pancreatic cancer; Tumor metastasis

Indexed keywords

ALPHA DYSTROGLYCAN; ANTERIOR GRADIENT 2 PROTEIN; BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 3 BINDING PROTEIN 1; ESTROGEN RECEPTOR; ONCOPROTEIN; PROTEIN DISULFIDE ISOMERASE; PROTEIN P53; TAMOXIFEN; UNCLASSIFIED DRUG;

AGR2 GENE; BIOLOGICAL ACTIVITY; BREAST CARCINOMA; CANCER RESISTANCE; CANCER SURVIVAL; COLORECTAL CANCER; DOWN REGULATION; ESOPHAGUS CANCER; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; ONCOGENE; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UPREGULATION;

EID: 79952245615     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.12.023     Document Type: Review

References (42)

1. Sive H.L., Hattori K., Weintraub H. Progressive determination during formation of the anteroposterior axis in Xenopus laevis. Cell 1989, 58:171-180.
2. Sive H., Bradley L. A sticky problem: the Xenopus cement gland as a paradigm for anteroposterior patterning. Dev. Dyn. 1996, 205:265-280.
3. Aberger F., Weidinger G., Grunz H., Richter K. Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2. Mech. Dev. 1998, 72:115-130.
4. Myung J.K., Frischer T., Afjehi-Sadat L., Pollak A., Lubec G. Mass spectrometrical analysis of the processed metastasis-inducing anterior gradient protein 2 homolog reveals 100% sequence coverage. Amino Acids 2008, 35:485-494.
5. Kumar A., Godwin J.W., Gates P.B., Garza-Garcia A.A., Brockes J.P. Molecular basis for the nerve dependence of limb regeneration in an adult vertebrate. Science 2007, 318:772-777.
6. Shih L.J., Lu Y.F., Chen Y.H., Lin C.C., Chen J.A., Hwang S.P. Characterization of the agr2 gene, a homologue of X. laevis anterior gradient 2, from the zebrafish, Danio rerio. Gene Expres. Patterns 2007, 7:452-460.
7. Novoselov V.V., Alexandrova E.M., Ermakova G.V., Zaraisky A.G. Expression zones of three novel genes abut the developing anterior neural plate of Xenopus embryo. Gene Expres. Patterns 2003, 3:225-230.
8. Xia J.H., Jiang J., Shi Y.H., Gui J.F. Predominant expression and cellular distribution of fish Agr2 in renal collecting system. Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 2009, 152:397-404.
9. Thompson D.A., Weigel R.J. HAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines. Biochem. Biophys. Res. Commun. 1998, 251:111-116.
10. Zheng W., Rosenstiel P., Huse K., Sina C., Valentonyte R., Mah N., Zeitlmann L., Grosse J., Ruf N., Nurnberg P., Costello C.M., Onnie C., Mathew C., Platzer M., Schreiber S., Hampe J. Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease. Genes Immun. 2006, 7:11-18.
11. Fletcher G.C., Patel S., Tyson K., Adam P.J., Schenker M., Loader J.A., Daviet L., Legrain P., Parekh R., Harris A.L., Terrett J.A. HAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan. Brit. J. Cancer 2003, 88:579-585.
12. Pohler E., Craig A.L., Cotton J., Lawrie L., Dillon J.F., Ross P., Kernohan N., Hupp T.R. The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage. Mol. Cell Proteomics 2004, 3:534-547.
13. Persson S., Rosenquist M., Knoblach B., Khosravi-Far R., Sommarin M., Michalak M. Diversity of the protein disulfide isomerase family: identification of breast tumor induced Hag2 and Hag3 as novel members of the protein family. Mol. Phylogenet. Evol. 2005, 36:734-740.
14. Park S.W., Zhen G., Verhaeghe C., Nakagami Y., Nguyenvu L.T., Barczak A.J., Killeen N., Erle D.J. The protein disulfide isomerase AGR2 is essential for production of intestinal mucus. Proc. Natl. Acad. Sci. USA 2009, 106:6950-6955.
15. Maslon M.M., Hrstka R., Vojtesek B., Hupp T.R. A divergent substrate-binding loop within the pro-oncogenic protein anterior gradient-2 forms a docking site for Reptin. J. Mol. Biol. 2010, 404:418-438.
16. Jessop C.E., Watkins R.H., Simmons J.J., Tasab M., Bulleid N.J. Protein disulphide isomerase family members show distinct substrate specificity: P5 is targeted to BiP client proteins. J. Cell Sci. 2009, 122:4287-4295.
17. Rowe M.L., Ruddock L.W., Kelly G., Schmidt J.M., Williamson R.A., Howard M.J. Solution structure and dynamics of ERp18, a small endoplasmic reticulum resident oxidoreductase. Biochemistry 2009, 48:4596-4606.
18. Zhang Y., Ali T.Z., Zhou H., D'Souza D.R., Lu Y., Jaffe J., Liu Z., Passaniti A., Hamburger A.W. ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer. Cancer Res. 2010, 70:240-248.
19. Liu D., Rudland P.S., Sibson D.R., Platt-Higgins A., Barraclough R. Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas. Cancer Res. 2005, 65:3796-3805.
20. Boonstra J.J., van Marion R., Beer D.G., Lin L., Chaves P., Ribeiro C., Pereira A.D., Roque L., Darnton S.J., Altorki N.K., Schrump D.S., Klimstra D.S., Tang L.H., Eshleman J.R., Alvarez H., Shimada Y., van Dekken H., Tilanus H.W., Dinjens W.N. Verification and unmasking of widely used human esophageal adenocarcinoma cell lines. J. Natl. Cancer Inst. 2010, 102:271-274.
21. Wang Z., Hao Y., Lowe A.W. The adenocarcinoma-associated antigen, AGR2, promotes tumor growth, cell migration, and cellular transformation. Cancer Res. 2008, 68:492-497.
22. Zweitzig D.R., Smirnov D.A., Connelly M.C., Terstappen L.W., O'Hara S.M., Moran E. Physiological stress induces the metastasis marker AGR2 in breast cancer cells. Mol. Cell Biochem. 2007, 306:255-260.
23. Hrstka R., Nenutil R., Fourtouna A., Maslon M.M., Naughton C., Langdon S., Murray E., Larionov A., Petrakova K., Muller P., Dixon M.J., Hupp T.R., Vojtesek B. The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers. Oncogene 2010, 29:4838-4847.
24. Innes H.E., Liu D., Barraclough R., Davies M.P., O'Neill P.A., Platt-Higgins A., de Silva Rudland S., Sibson D.R., Rudland P.S. Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients. Brit. J. Cancer 2006, 94:1057-1065.
25. Fritzsche F.R., Dahl E., Dankof A., Burkhardt M., Pahl S., Petersen I., Dietel M., Kristiansen G. Expression of AGR2 in non small cell lung cancer. Histol. Histopathol. 2007, 22:703-708.
26. Vanderlaag K.E., Hudak S., Bald L., Fayadat-Dilman L., Sathe M., Grein J., Janatpour M.J. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and surviving. Breast Cancer Res. 2010, 12:R32.
27. Stendahl M., Kronblad A., Ryden L., Emdin S., Bengtsson N.O., Landberg G. Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients. Brit. J. Cancer 2004, 90:1942-1948.
28. Feldman B.J., Feldman D. The development of androgen-independent prostate cancer. Nat. Rev. Cancer 2001, 1:34-45.
29. Zhang Y., Linn D., Liu Z., Melamed J., Tavora F., Young C.Y., Burger A.M., Hamburger A.W. EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance. Mol. Cancer Ther. 2008, 7:3176-3186.
30. Kristiansen G., Pilarsky C., Wissmann C., Kaiser S., Bruemmendorf T., Roepcke S., Dahl E., Hinzmann B., Specht T., Pervan J., Stephan C., Loening S., Dietel M., Rosenthal A. Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. J. Pathol. 2005, 205:359-376.
31. Zhang Y., Forootan S.S., Liu D., Barraclough R., Foster C.S., Rudland P.S., Ke Y. Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients. Prostate Cancer Prostatic Dis. 2007, 10:293-300.
32. Iacobuzio-Donahue C.A., Ashfaq R., Maitra A., Adsay N.V., Shen-Ong G.L., Berg K., Hollingsworth M.A., Cameron J.L., Yeo C.J., Kern S.E., Goggins M., Hruban R.H. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res. 2003, 63:8614-8622.
33. Missiaglia E., Blaveri E., Terris B., Wang Y.H., Costello E., Neoptolemos J.P., Crnogorac-Jurcevic T., Lemoine N.R. Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis. Int. J. Cancer 2004, 112:100-112.
34. Wilson C.L., Sims A.H., Howell A., Miller C.J., Clarke R.B. Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue. Endocr. Relat. Cancer 2006, 13:617-628.
35. Zhang J.S., Gong A., Cheville J.C., Smith D.I., Young C.Y. AGR2, an androgen-inducible secretory protein overexpressed in prostate cancer. Genes Chromosomes Cancer 2005, 43:249-259.
36. Kreiger N., Lacroix J., Sloan M. Hormonal factors and pancreatic cancer in women. Ann. Epidemiol. 2001, 11:563-567.
37. Ramachandran V., Arumugam T., Wang H., Logsdon C.D. Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. Cancer Res. 2008, 68:7811-7818.
38. Vivekanandan P., Micchelli S.T., Torbenson M. Anterior gradient-2 is overexpressed by fibrolamellar carcinomas. Hum. Pathol. 2009, 40:293-299.
39. Valladares-Ayerbes M., Diaz-Prado S., Reboredo M., Medina V., Iglesias-Diaz P., Lorenzo-Patino M.J., Campelo R.G., Haz M., Santamarina I., Anton-Aparicio L.M. Bioinformatics approach to mRNA markers discovery for detection of circulating tumor cells in patients with gastrointestinal cancer. Cancer Detect. Prev. 2008, 32:236-250.
40. Smirnov D.A., Zweitzig D.R., Foulk B.W., Miller M.C., Doyle G.V., Pienta K.J., Meropol N.J., Weiner L.M., Cohen S.J., Moreno J.G., Connelly M.C., Terstappen L.W., O'Hara S.M. Global gene expression profiling of circulating tumor cells. Cancer Res. 2005, 65:4993-4997.
41. Reid B.J., Sanchez C.A., Blount P.L., Levine D.S. Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression. Gastroenterology 1993, 105:119-129.
42. Zhu H., Lam D.C., Han K.C., Tin V.P., Suen W.S., Wang E., Lam W.K., Cai W.W., Chung L.P., Wong M.P. High resolution analysis of genomic aberrations by metaphase and array comparative genomic hybridization identifies candidate tumour genes in lung cancer cell lines. Cancer Lett. 2007, 245:303-314.